He will succeed Annaswamy Vaidheesh, who is set to retire from the company effective March 31, 2020, GlaxoSmithKline Pharmaceuticals said in a statement.
Venkatesh has more than 24 years of diverse experience in pharmaceuticals and healthcare, and has a strong track record of success in multiple roles within GSK, it added.
He is a registered pharmacist with a master's in pharmacy, the statement said.
"I warmly welcome Sridhar to lead GSK in our next phase of growth to serve the patients of India. I would also like to take this opportunity to thank Vaidheesh for his leadership during the last 5 years," GlaxoSmithKline Pharmaceuticals Chairperson Renu Karnad said.
Shares of GlaxoSmithKline Pharmaceuticals were trading at Rs 1,316.95 per scrip on the BSE, up 1.26 per cent from its previous close. AKT BAL